- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07385118
Daily Fluctuations in Brain-Derived Neurotrophic Factor and Cognition: Effects of Vigorous Exercise
Daily Fluctuations in Brain-Derived Neurotrophic Factor and Cognitive Performance: Effects of Acute Physical Exercise
Cognitive functions are fundamental to everyday life, underpinning the mental processes required to perform any activity. Recent studies have shown that improved cognitive performance is associated with elevated levels of brain-derived neurotrophic factor (BDNF), which can be increased through an acute bout of physical activity. However, daily variations of BDNF serum and plasma remain poorly characterised and are not fully understood, and their correlation with daily variations in cognitive performance has not been previously explored. This study examines:
1) the correlation between daily BDNF fluctuations and cognitive performance. 2) whether a single session of exercise can elevate BDNF levels and lead to measurable cognitive improvements.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
PD
-
Padua, PD, Italy, 10034
- Department of Biomedical Sciences, University of Padua
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- an age between 18-40 years old
- no history of mental or physical diseases (of a neurological, psychogenic, musculoskeletal, cardiorespiratory or systemic nature)
- MoCA score higher than 26
Exclusion Criteria:
- smokers
- individuals experiencing sleep-wake cycle disturbances in the week prior to the study
- consumers of medications with CNS effects
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: BDNF arm
Every subject will be tested on day 1 and day 2 with the same protocol.
Blood samples will be collected at five time points throughout the workday: 09:00 (T1), 11:00 (T2), 13:00 (T3), 15:00 (T4), and 17:00 (T5), to assess potential diurnal variations in BDNF.
Cognitive performance will be evaluated using the Psychomotor Vigilance Test (PVT), the Flanker task, and the Digit Span Backwards test at T1, T3, and T5.
On the second intervention day, the same protocol will be followed, with the addition of a 15-minute single bout of high-intensity physical activity executed at T4.
|
A five-minute bout of exercise at high intensity (75% of HRmax) repeated for two rounds with a minute rest between rounds.
The bout consists of 5 exercises: BW squat, jumping jacks, lunges, crunches and step up.
The modality is, in one minute for every exercise, 30 seconds of work and 30 seconds of rest
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Levels of Serum BDNF (ng/ml)
Time Frame: blood samples were collected on day one and day two at five specific time points: 9 a.m. (t1), 11 a.m. (t2), 1 p.m. (t3), 3 p.m. (t4), 5 p.m. (t5)
|
Blood samples for serum BDNF concentration analysis were collected using a Clot Activator Tube (CAT) and gently swirled ten times, upside down.
They were then incubated at room temperature for 30 minutes to allow clot formation.
Subsequently, the samples were centrifuged at 1100 g and 4 °C for 10 minutes, and then, the serum was collected, aliquoted, and stored at -80 °C.
The analysis of BDNF was performed using an enzyme-linked immunosorbent assay (ELISA) kit, following the manufacturer's instructions (ab212166 - Human BDNF SimpleStep ELISA Kit).
|
blood samples were collected on day one and day two at five specific time points: 9 a.m. (t1), 11 a.m. (t2), 1 p.m. (t3), 3 p.m. (t4), 5 p.m. (t5)
|
|
inhibitory control
Time Frame: The test was performed for each participant on day one and two at three predefined time points 9 a.m. (t1), 1 p.m. (t3), 5 p.m. (t5)
|
Inhibitory control was assessed with the Flanker Task.
During the task, participants are required to indicate the left-right orientation of a centrally presented stimulus while inhibiting attention to the potentially incongruent stimuli surrounding it (e.g., flankers on either side).
The principal outcomes for this task are total errors, the mean reaction time for incongruent and congruent stimuli, and the conflict cost (the difference between the mean reaction times for incongruent and congruent stimuli)
|
The test was performed for each participant on day one and two at three predefined time points 9 a.m. (t1), 1 p.m. (t3), 5 p.m. (t5)
|
|
sustained attention and vigilance
Time Frame: The test was performed for each participant on day one and two at three predefined time points 9 a.m. (t1), 1 p.m. (t3), 5 p.m. (t5)
|
Sustained attention and vigilance were assessed with the Psychomotor Vigilance Task.
Participants are presented with a visual stimulus (a simple light) that appears at random inter-stimulus intervals (between 2 and 10 seconds).
When the stimulus appears, the participants are required to respond as quickly as possible.
The primary outcome for this test is the mean reaction time
|
The test was performed for each participant on day one and two at three predefined time points 9 a.m. (t1), 1 p.m. (t3), 5 p.m. (t5)
|
|
working memory (short-term memory)
Time Frame: The test was performed for each participant on day one and two at three predefined time points 9 a.m. (t1), 1 p.m. (t3), 5 p.m. (t5)
|
Working memory was assessed with the Digit Span Backwards, in which participants are presented with a series of digits and then asked to recall them in reverse order.
The main outcome for this test is the memory span.
|
The test was performed for each participant on day one and two at three predefined time points 9 a.m. (t1), 1 p.m. (t3), 5 p.m. (t5)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Antonio Paoli, University of Padua Department of Biomedical Sciences
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DAILYBDNF
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on BDNF
-
University of MinnesotaTerminated
-
Aksaray University Training and Research HospitalCompletedFootball Players | BDNF | Small Side GameTurkey (Türkiye)
-
Aksaray University Training and Research HospitalCompletedHealthy | Lactate | Exercise Intensity | BDNFTurkey (Türkiye)
-
Aksaray University Training and Research HospitalCompletedCognitive Performance | Lactate | Exercise Intensity | BDNFTurkey (Türkiye)
-
University of California, Los AngelesApplied BioClinical Inc.CompletedCognitive Function | Affect | Brain-derived Neurotrophic Factor (BDNF)United States
-
Bayburt UniversityCompletedCognitive Function | Irisin | Exercise Physiology | Adipokine Response | Brain-Derived Neurotrophic Factor (BDNF) | Omentin-1Turkey (Türkiye)
-
University of LjubljanaActive, not recruitingIrisin | Resistance Exercise | Lactate | BDNF | Healthy Young Adult | Stroop TestSlovenia
-
Cemre AydeğerActive, not recruitingChemotherapy | Cognitive Functions | BDNFTurkey
-
Ana Flávia Marçal PessoaFederal University of São PauloCompletedStress | Well-being | Memory Impairment | Methylation | BDNFBrazil
-
Hospital de Clinicas de Porto AlegreRecruitingtDCS | EEG | Duloxetine | Fibromyalgia (FM) | BDNFBrazil
Clinical Trials on Exercise
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
University of Alabama at BirminghamCompletedCystic FibrosisUnited States
-
University College CorkRecruitingDepressive Disorder, MajorIreland
-
Sahmyook UniversityRecruitingChronic Nonspecific Neck PainKorea, Republic of
-
Uskudar UniversityCompleted
-
Yuksek Ihtisas UniversityCompletedDementia | Frailty | Cognitive Function | Reaction Time | Aerobic Exercise | Balance ExerciseTurkey
-
National Taiwan Normal UniversityCompletedAging | Cognitive DeclineTaiwan